| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |